Skip to main content
SpringerLink
Log in

Posterior Pole Manifestations of Hematologic Diseases

  • Chapter
  • First Online:
Retinal and Choroidal Manifestations of Selected Systemic Diseases

  • 1257 Accesses

Abstract

Hematologic diseases often share clinical features within the choroid and retina because of the limited number of cell line or lines affected. No one chorioretinal change is specific for a particular hematologic anomaly; rather, it is the context and pattern that help guide clinical diagnoses. Retinal and choroidal manifestations of hematologic illness may be critical not only in identifying new or recurrent illness but also in ultimately reducing patient morbidity and mortality. Therefore, it is paramount that an open and regular dialogue be maintained between a patients hematologist and ophthalmologist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Payne AS. The cleere observer: a biography of Antoni van Leeuwenhoek. London: Macmillan; 1970.

    Google Scholar 

  2. Kleinzeller A. William Hewson’s studies of red blood corpuscles and the evolving concept of a cell membrane. Am J Physiol. 1996;271(1 Pt 1):C1–8. Jul.

    PubMed  CAS  Google Scholar 

  3. Tan SY, Brown J. Rudolph Virchow (1821–1902): “pope of pathology”. Singapore Med J. 2006;47(7): 567–8.

    PubMed  CAS  Google Scholar 

  4. Behrman S. Richard Liebreich, 1830–1917. First iconographer of the fundus oculi. Br J Ophthalmol. 1968;52(4):335–8.

    PubMed  CAS  Google Scholar 

  5. Adamson JW, Longo DL. Anemia and polycythemia. In: Kasper DL et al., editors. Harrison’s principles of internal medicine. New York: McGraw-Hill; 2005.

    Google Scholar 

  6. Merin S, Freund M. Retinopathy in severe anemia. Am J Ophthalmol. 1968;66:1102–6.

    PubMed  CAS  Google Scholar 

  7. Rubenstein RA, Yanoff M, Albert DM. Thrombocytopenia, anemia, and retinal hemorrhage. Am J Ophthalmol. 1968;65:435–9.

    PubMed  CAS  Google Scholar 

  8. Carraro MC, Rossetti L, Gerli GC. Prevalence of retinopathy in patients with anemia or thrombocytopenia. Eur J Haematol. 2001;67:238–44.

    PubMed  CAS  Google Scholar 

  9. Aisen MI, Bacon BR, Goodman AM, et al. Retinal abnormalities associated with anemia. Arch Ophthalmol. 1983;101:1049.

    PubMed  CAS  Google Scholar 

  10. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653–62.

    PubMed  CAS  Google Scholar 

  11. Watanabe D, Suzuma K, Matsui S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med. 2005;353:782–92.

    PubMed  CAS  Google Scholar 

  12. Wechsler DZ, Tay TS, McKay DL. Life-threatening haematological disorders presenting with ophthalmic manifestations. Clin Experiment Ophthalmol. 2004;32:547–50.

    PubMed  Google Scholar 

  13. Wong VG, Bodey GP. Hemorrhagic retinoschisis due to aplastic anemia. Arch Ophthalmol. 1968;80:433–5.

    PubMed  CAS  Google Scholar 

  14. Bahar I, Weinberger D, Kramer M, Axer-Siegel R. Retinal vasculopathy in Fanconi anemia: a case report. Retina. 2005;25:799–800.

    PubMed  Google Scholar 

  15. Chai SM, Mathur R, Ong SG. Retinal vasculopathy in Fanconi anemia. Ophthalmic Surg Lasers Imaging. 2009;40:498–500.

    PubMed  Google Scholar 

  16. Yahia SB, Touffahi SA, Zeghidi H, et al. Ocular neovascularization in a patient with Fanconi anemia. Can J Ophthalmol. 2006;41:778–9.

    PubMed  Google Scholar 

  17. Joneckis CC, Ackley RL, Orringer EP, et al. Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulation reticulocytes in sickle cell anemia. Blood. 1993;82:3548–55.

    PubMed  CAS  Google Scholar 

  18. Nagpal KC, Asdourian G, Goldbaum M, et al. Angioid streaks and sickle haemoglobinopathies. Br J Ophthalmol. 1976;60:31–4.

    PubMed  CAS  Google Scholar 

  19. Aessopos A, Voskaridou E, Kavouklis E, et al. Angioid streaks in sickle-thalassemia. Am J Ophthalmol. 1994;117:589–92.

    PubMed  CAS  Google Scholar 

  20. Emerson GG, et al. Sickle cell retinopathy. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson P, ­editors. The Retina. 4th ed. Philadelphia: Mosby; 2005.

    Google Scholar 

  21. Romayanada N, Goldberg MF, Green WR. Histopathology of sickle cell retinopathy. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:OP642–76.

    PubMed  CAS  Google Scholar 

  22. Goldbaum MH. Retinal depression sign indicating a small retinal infarct. Am J Ophthalmol. 1978;86:45–55.

    PubMed  CAS  Google Scholar 

  23. Dizon RV, Jampol LM, Goldberg MF, Juarez C. Choroidal occlusive disease in sickle cell hemoglobinopathies. Surv Ophthalmol. 1979;23:297–306.

    PubMed  CAS  Google Scholar 

  24. Fine LC, Petrovic’ V, Irvine AR, Bhisitkul RB. Spontaneous central retinal artery occlusion in hemoglobin sickle cell disease. Am J Ophthalmol. 2000;129:680–1.

    PubMed  CAS  Google Scholar 

  25. Liem RI, Calamaras DM, Chhabra MS, et al. Sudden-onset blindness in sickle cell disease due to retinal artery occlusion. Pediatr Blood Cancer. 2008;50:624–7.

    PubMed  Google Scholar 

  26. Clarke WN, Vomiero G, Leonard BC. Bilateral simultaneous retinal arteriolar obstruction in a child with hemoglobin SS sickle cell disease. J AAPOS. 2001;5:126–8.

    PubMed  CAS  Google Scholar 

  27. Cusick M, Toma HS, Hwang TS, et al. Binasal visual field defects from simultaneous bilateral retinal infarctions in sickle cell disease. Am J Ophthalmol. 2007;143:893–6.

    PubMed  Google Scholar 

  28. Condon PI, Serjeant GR. Behaviour of untreated proliferative sickle retinopathy. Br J Ophthalmol. 1980;64:404–11.

    PubMed  CAS  Google Scholar 

  29. Goldberg MF. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol. 1971;71:369–74.

    Google Scholar 

  30. Rednam KR, Jampol LM, Goldberg MF. Scatter retinal photocoagulation for proliferative sickle cell retinopathy: a long term follow-up. Ophthalmology. 1982;98:594–9.

    Google Scholar 

  31. Kimmel AS, Magargal LE, Stephens RF, Cruess AF. Peripheral circumferential retinal scatter photocoagulation for the treatment of proliferative sickle retinopathy: an update. Ophthalmology. 1986;93:1429–34.

    PubMed  CAS  Google Scholar 

  32. Condon P, Jampol LM, Farber MD, et al. A randomized clinical trial of feeder vessel photocoagulation of proliferative sickle cell retinopathy. II. Update and analysis of risk factors. Ophthalmology. 1984;91:1496–8.

    PubMed  CAS  Google Scholar 

  33. Jacobson MS, Gagliano DA, Cohen SB, et al. A randomized clinical trial of feeder vessel photocoagulation of sickle cell retinopathy. A long-term follow-up. Ophthalmology. 1991;98:581–5.

    PubMed  CAS  Google Scholar 

  34. Cao J, Mathews MK, McLeod DS, et al. Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol. 1999;83:838–46.

    PubMed  CAS  Google Scholar 

  35. Siqueira RC, Costa RA, Scott IU, et al. Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy. Acta Ophthalmol Scand. 2006;84:834–5.

    PubMed  Google Scholar 

  36. Shaikh S. Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy. Indian J Ophthalmol. 2008;56:259.

    PubMed  Google Scholar 

  37. Jampol LM, Green Jr JL, Goldberg MF, Peyman GA. An update on vitrectomy surgery and retinal detachment repair in sickle cell disease. Arch Ophthalmol. 1982;100:591–3.

    PubMed  CAS  Google Scholar 

  38. Ryan SJ, Goldberg MF. Anterior segment ischemia following scleral buckling in sickle cell hemoglobinopathy. Am J Ophthalmol. 1971;72:35–50.

    PubMed  CAS  Google Scholar 

  39. Cartwright MJ, Blair CJ, Combs JL, Stratford TP. Anterior segment ischemia: a complication of retinal detachment repair in a patient with sickle cell trait. Ann Ophthalmol. 1990;22:333–4.

    PubMed  CAS  Google Scholar 

  40. Leen JS, Ratnakaram R, Del Priore LV, et al. Anterior segment ischemia after vitrectomy in sickle cell disease. Retina. 2002;22:216–9.

    PubMed  Google Scholar 

  41. Cohen SB, Fletcher ME, Goldberg MF, Jednock NJ. Diagnosis and management of ocular complications of sickle hemoglobinopathies: part V. Ophthalmic Surg. 1986;17:369–74.

    PubMed  CAS  Google Scholar 

  42. Brazier DJ, Gregor ZJ, Blach RK, et al. Retinal detachment in patients with proliferative sickle cell retinopathy. Trans Ophthalmol Soc U K. 1986;105: 100–5.

    PubMed  Google Scholar 

  43. Morgan CM, D’Amico DJ. Vitrectomy surgery in proliferative sickle retinopathy. Am J Ophthalmol. 1987;104:133–8.

    PubMed  CAS  Google Scholar 

  44. Pulido JS, Flynn Jr HW, Clarkson JG, Blankenship GW. Pars plana vitrectomy in the management of complications of proliferative sickle retinopathy. Arch Ophthalmol. 1988;106:1553–7.

    PubMed  CAS  Google Scholar 

  45. Kato GJ, Gladwin MT. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA. 2008;300:2638–46.

    PubMed  CAS  Google Scholar 

  46. Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009;361:2309–17.

    PubMed  CAS  Google Scholar 

  47. Khwarg SG, Feldman S, Ligh J, Straatsma BR. Exchange transfusion in sickling maculopathy. Retina. 1985;5:227–9.

    PubMed  CAS  Google Scholar 

  48. Al-Abdulla NA, Haddock TA, Kerrison JB, Goldberg MF. Sickle cell disease presenting with extensive peri-macular arteriolar occlusions in a nine-year-old boy. Am J Ophthalmol. 2001;131:275–6.

    PubMed  CAS  Google Scholar 

  49. Taher A, Bashshur Z, Shamseddeen WA, et al. Ocular findings among thalassemia patients. Am J Ophthalmol. 2006;142:704–5.

    PubMed  Google Scholar 

  50. Davies SC, Marcus RE, Hungerford JL, et al. Ocular toxicity of high-dose intravenous desferrioxamine. Lancet. 1983;2:181–4.

    PubMed  CAS  Google Scholar 

  51. Lakhanpal V, Schocket SS, Jiji R. Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy. Ophthalmology. 1984;91:443–51.

    PubMed  CAS  Google Scholar 

  52. Arora A, Wren S, Evans KG. Desferrioxamine related maculopathy: a case report. Am J Hematol. 2004;76:386–8.

    PubMed  Google Scholar 

  53. Baath JS, Lam WC, Kirby M, Chun A. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population. Retina. 2008;28:894–9.

    PubMed  Google Scholar 

  54. Lai TY, Lee GK, Chan WM, Lam DS. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion. Br J Ophthalmol. 2006;90:243–4.

    PubMed  CAS  Google Scholar 

  55. Pinna A, Carru C, Solinas G, et al. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion. Invest Ophthalmol Vis Sci. 2007;48: 2747–52.

    PubMed  Google Scholar 

  56. Scheuerle AF, Serbecic N, Beutelspacher SC. Paroxysmal nocturnal hemoglobinuria may cause retinal vascular occlusions. Int Ophthalmol. 2009;29: 187–90.

    PubMed  Google Scholar 

  57. Song MH, Roh YJ. Bilateral serous retinal detachment as the first manifestation of paroxysmal nocturnal haemoglobinuria. Eye (Lond). 2007;21:437–9.

    Google Scholar 

  58. Hauser D, Barzilai N, Zalish M, et al. Bilateral papilledema with retinal hemorrhages in association with cerebral venous sinus thrombosis and paroxysmal nocturnal hemoglobinuria. Am J Ophthalmol. 1996;122:592–3.

    PubMed  CAS  Google Scholar 

  59. Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet. 2009;373:759–67.

    PubMed  CAS  Google Scholar 

  60. Oner A, Ozkiris A, Dogan H, et al. Bilateral macular hemorrhage associated with autoimmune hemolytic anemia. Retina. 2005;25:1089–90.

    PubMed  Google Scholar 

  61. Suzuki J, Goto H, Usui M, Sakai J. Serous retinal detachment in a patient with aplastic anemia associated with parvovirus B19 infection. Graefes Arch Clin Exp Ophthalmol. 2007;245:324–6.

    PubMed  Google Scholar 

  62. Chew FL, Tajunisah I. Retinal phlebitis associated with autoimmune hemolytic anemia. Ocul Immunol Inflamm. 2009;17:394–5.

    PubMed  Google Scholar 

  63. Kremer Hovinga JA, Studt JD, Lämmle B. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP). Pathophysiol Haemost Thromb. 2003;33:417–21.

    PubMed  Google Scholar 

  64. Gerber A, Karch H, Allerberger F, Verweyen HM. Clinical course and the role of shiga toxin-producing Escherichia coliinfection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. J Infect Dis. 2002;186:493–500.

    PubMed  Google Scholar 

  65. Bolling JP. Disseminated intravascular coagulopathy and related vasculopathies. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson P, editors. The retina. 4th ed. Philadelphia: Mosby; 2005.

    Google Scholar 

  66. Okwuosa TM, Lee EW, Starosta M, et al. Purtscher-like retinopathy in a patient with adult-onset Still’s disease and concurrent thrombotic thrombocytopenic purpura. Arthritis Rheum. 2007;57:182–5.

    PubMed  Google Scholar 

  67. Costa JR, Krause M, Friedman E, D’Amico DJ. Central retinal vein occlusion in a patient with thrombotic thrombocytopenic purpura. Am J Ophthalmol. 2001;131:669–71.

    PubMed  CAS  Google Scholar 

  68. Schwartz SG, McPherson AR, Mieler WF. Bilateral combined occlusion of the central retinal artery and vein secondary to thrombotic thrombocytopenic purpura. Arch Ophthalmol. 2000;118:1304–5.

    PubMed  CAS  Google Scholar 

  69. Issa SA, Qasem Q. Central retinal vein occlusion associated with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: complete resolution is possible. J Postgrad Med. 2007;53:183–4.

    PubMed  CAS  Google Scholar 

  70. Schwartz SG, Hickey M, Puliafito CA. Bilateral CRAO and CRVO from thrombotic thrombocytopenic purpura: OCT findings and treatment with triamcinolone acetonide and bevacizumab. Ophthalmic Surg Lasers Imaging. 2006;37:420–2.

    PubMed  Google Scholar 

  71. Au A, O’Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol. 2004;32:87–100.

    PubMed  Google Scholar 

  72. Al-Abdulla NA, Thompson JT, LaBorwit SE. Simultaneous bilateral central retinal vein occlusion associated with anticardiolipin antibodies in leukemia. Am J Ophthalmol. 2001;132:266–8.

    PubMed  CAS  Google Scholar 

  73. Glacet-Bernard A, Bayani N, Chretien P, et al. Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Arch Ophthalmol. 1994;112:790–5.

    PubMed  CAS  Google Scholar 

  74. Cobo-Soriano R, Sánchez-Ramón S, Aparicio MJ, et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case–control study. Am J Ophthalmol. 1999;128: 725–32.

    PubMed  CAS  Google Scholar 

  75. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346:752–63.

    PubMed  CAS  Google Scholar 

  76. Castañón C, Amigo MC, Bañales JL, et al. Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology. 1995;102:256–62.

    PubMed  Google Scholar 

  77. Tang J, Fillmore G, Nussenblatt RB. Antiphospholipid antibody syndrome mimicking serpiginous choroidopathy. Ocul Immunol Inflamm. 2009;17: 278–81.

    PubMed  Google Scholar 

  78. Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349:1133–8.

    PubMed  CAS  Google Scholar 

  79. Magee CC, Coggins MP, Foster CS, et al. Case records of the Massachusetts General Hospital. Case 2–2008. A 38-year-old woman with postpartum visual loss, shortness of breath, and renal failure. N Engl J Med. 2008;358:275–89.

    PubMed  CAS  Google Scholar 

  80. Rubenstein RA, Albert DM, Scheie HG. Ocular complications of hemophilia. Arch Ophthalmol. 1966;76:231–2.

    PubMed  CAS  Google Scholar 

  81. Hon C, Liu H, Chan J. Acquired factor VIII inhibitor presenting as macular haemorrhage. Haemophilia. 2005;11:164–6.

    PubMed  CAS  Google Scholar 

  82. Maguluri S, Bueno CL, Fuller IB, et al. Delayed suprachoroidal hemorrhage and factor VIII deficiency. Am J Ophthalmol. 2005;139:195–7.

    PubMed  Google Scholar 

  83. Kobayashi H, Honda Y. Intraocular hemorrhage in a patient with hemophilia. Metab Ophthalmol. 1984–1985;8:27–30.

    Google Scholar 

  84. Rothkoff L, Biedner B, Shoham K. Bilateral cataract: extraction in classic haemophilia with retrobulbar anaesthesia and peripheral iridectomy. Br J Ophthalmol. 1977;61:765–6.

    PubMed  CAS  Google Scholar 

  85. Jijina F, Ghosh K, Madkaikar M, Mohanty D. Ophthalmic surgery in haemophilia. Haemophilia. 2001;7:464–7.

    PubMed  CAS  Google Scholar 

  86. Priluck IA, Howe RB, Eifrig DE, et al. Retinal surgery complicated by a spontaneously acquired factor VIII inhibitor. Am J Ophthalmol. 1978;86:27–30.

    PubMed  CAS  Google Scholar 

  87. Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109:1536.

    PubMed  Google Scholar 

  88. Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol. 1992;82:358.

    PubMed  CAS  Google Scholar 

  89. Sekeres MA, Schoonen WM, Kantargian H, et al. Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst. 2008;100:1542.

    PubMed  Google Scholar 

  90. Passmore SJ, Hann IM, STiller CA, et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood. 1995;85:1742.

    PubMed  CAS  Google Scholar 

  91. Albitar M, Manshouri T, Shen Y, et al. Myelodysplastic syndrome is not merely “preleukemia”. Blood. 2002;100:791.

    PubMed  CAS  Google Scholar 

  92. Kezuka T, Usui N, Suzuki E, Wakasugi K, Usui M. Ocular complications in myelodysplastic syndromes as preleukemic disorders. Jpn J Ophthalmol. 2005;49(5):377–83. Sep–Oct.

    PubMed  Google Scholar 

  93. Neukirchen J, Blum S, Kuendgen A, Strupp C, Aivado M, Haas R, Aul C, Gattermann N, Germing U. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes. Eur J Haematol. 2009;83(5):477–82.

    PubMed  Google Scholar 

  94. Noble KG, Greenberg J. Appearance of birdshot retinochoroidopathy in a patient with myelodysplasia syndrome. Am J Ophthalmol. 1998;125(1): 108–9.

    PubMed  CAS  Google Scholar 

  95. LeHoang P, Sterkers M, Thillaye B, de Kozak Y, Coscas G, Faure JP. Primate model of uveoretinitis and vasculitis/experimental autoimmune uveoretinitis induced in cynomolgus monkeys by retinal s antigen. Ophthalmic Res. 2008;40(3–4):181–8.

    PubMed  CAS  Google Scholar 

  96. Yamagami S, Ando K, Akahoshi T, Yamashita H. Exophthalmos in myelodysplastic syndrome. Acta Ophthalmol (Copenh). 1991;69(2):261–5.

    CAS  Google Scholar 

  97. Smith DL, Skuta GL, Trobe JD, Weinberg AB. Angle-closure glaucoma as initial presentation of myelodysplastic syndrome. Can J Ophthalmol. 1990;25(6):306–8.

    PubMed  CAS  Google Scholar 

  98. Brouzas D, Charakidas A, Ladas I, Apostolopoulos M. Nonarteritic anterior ischemic optic neuropathy associated with chronic anemia: a case series of myelodysplastic syndrome patients. Clin Ophthalmol. 2009;3:133–7.

    PubMed  Google Scholar 

  99. Kilpivaara O, Levine RL. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukemia. 2008;22(10):1813–7.

    PubMed  CAS  Google Scholar 

  100. Rohrbacher M, Hasford J. Epidemiology of chronic myeloid leukaemia (CML). Best Pract Res Clin Haematol. 2009;22(3):295–302. Sep.

    PubMed  Google Scholar 

  101. Rosenthal AR. Ocular manifestation of leukemia. Ophthalmology. 1983;83:899–905.

    Google Scholar 

  102. Shields JA, Shields CL. Intraocular lymphoid tumors and leukemias. In: Intraocular tumors: a text and atlas. Philadelphia: Saunders; 1992.

    Google Scholar 

  103. Nobacht S, Vandoninck KF, Deutman AF, Klevering BJ. Peripheral retinal nonperfusion associated with chronic myeloid leukemia. Am J Ophthalmol. 2003;135(3):404–6.

    PubMed  Google Scholar 

  104. Shammas F, Meyer P, Heikkila R, Apeland T, Gøransson L, Berland J, Kjellevold K. Thrombotic microangiopathy in a patient with chronic myelogenous leukemia on hydroxyurea. Acta Haematol. 1997;97(3):184–6.

    PubMed  CAS  Google Scholar 

  105. Guymer RH, Cairns JD, O’Day J. Benign intracranial hypertension in chronic myeloid leukemia. Aust N Z J Ophthalmol. 1993;21(3):181–5. Aug.

    PubMed  CAS  Google Scholar 

  106. Kwon SI, Lee DH, Kim YJ. Optic disc edema as a possible complication of imatinib mesylate (Gleevec). Jpn J Ophthalmol. 2008;52(4):331–3. Jul–Aug.

    PubMed  Google Scholar 

  107. Sirhan S, Fairbanks VF, Tefferi A. Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility. Cancer. 2005;104(1):213–5.

    PubMed  Google Scholar 

  108. Remacha AF, Montserrat I, Santamaria A, et al. Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study. Haematologica. 1997;82(4):406–10.

    PubMed  CAS  Google Scholar 

  109. Berlin NI. Diagnosis and classification of polycythemias. Semin Hematol. 1975;12:339.

    PubMed  CAS  Google Scholar 

  110. Ania BJ, Suman VJ, Sobell JL, et al. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935–1989. Am J Hematol. 1994;47(2):89–93.

    PubMed  CAS  Google Scholar 

  111. Mirza AM, Ezzat S, Axelrad AA. Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro. Blood. 1997;89(6):1862–9.

    PubMed  CAS  Google Scholar 

  112. Dai CH, Krantz SB, Dessypris EN, et al. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-­macrophage colony-stimulating factor. Blood. 1992;80(4):891–9.

    PubMed  CAS  Google Scholar 

  113. Dai CH, Krantz SB, Sawyer ST. Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera. Blood. 1997;89(10):3574–81.

    PubMed  CAS  Google Scholar 

  114. Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M, Manarini S, Finazzi G, Cerletti C, Barbui T. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood. 2000;96(13):4261–6. Dec 15.

    PubMed  CAS  Google Scholar 

  115. Landolfi R, Marchioli R, Patrono C. Mechanisms of bleeding and thrombosis in myeloproliferative disorders. Thromb Haemost. 1997;78(1):617–21. Jul.

    PubMed  CAS  Google Scholar 

  116. Carter-Rosenhauch E. Diagnosis of polycythemia vera from the anamnesis and external eye symptoms. Am J Ophthalmol. 1951;34(10):1445–6.

    PubMed  CAS  Google Scholar 

  117. Jabaily J, Iland HJ, Laszlo J, et al. Neurologic manifestations of essential thrombocythemia. Ann Intern Med. 1983;99:513–8.

    PubMed  CAS  Google Scholar 

  118. Strassman I, Silverstone BZ, Seelenfreund MH, et al. Essential thrombocythemia: a rare cause of central retinal artery occlusion. Metab Pediatr Syst Ophthalmol. 1991;14:18–20.

    PubMed  CAS  Google Scholar 

  119. Ahn BY, Choi KD, Choi YJ, Jea SY, Lee JE. Isolated monocular visual loss as an initial manifestation of polycythemia vera. J Neurol Sci. 2007;258(1–2):151–3. Jul 15.

    PubMed  Google Scholar 

  120. Rothstein T. Bilateral, central retinal vein closure as the initial manifestation of polycythemia. Am J Ophthalmol. 1972;74(2):256–60. Aug.

    PubMed  CAS  Google Scholar 

  121. Parija S, Mohapatra MM, Pattnaik BK. Polycythemia vera presenting with bilateral papilledema: a rare case report. Indian J Ophthalmol. 2008;56(4):327–9. Jul–Aug.

    PubMed  CAS  Google Scholar 

  122. Tönz MS, Rigamonti V, Iliev ME. Simultaneous, bilateral anterior ischemic optic neuropathy (AION) in polycythemia vera: a case report. Klin Monbl Augenheilkd. 2008;225(5):504–6.

    PubMed  Google Scholar 

  123. Pless M, Rizzo 3rd JF, Shang J. Orbital apex syndrome: a rare presentation of extramedullary hematopoiesis: case report and review of literature. J Neurooncol. 2002;57(1):37–40. Mar.

    PubMed  Google Scholar 

  124. Havelius U, Berglund S, Falke P, Hindfelt B, Krakau T. Impaired dark adaptation in polycythemia. Improvement after treatment. Acta Ophthalmol Scand. 2000;78(1):53–7. Feb.

    PubMed  CAS  Google Scholar 

  125. Schafer AI. Thrombocytosis. N Engl J Med. 2004;350(12):1211–9. Mar 18.

    PubMed  CAS  Google Scholar 

  126. Schafer AI. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood. 2006;107(11):4214–22. Jun 1.

    PubMed  CAS  Google Scholar 

  127. Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976–1995. Am J Hematol. 1999;61(1):10–5. May.

    PubMed  CAS  Google Scholar 

  128. Ma X, Vanasse G, Cartmel B, Wang Y, Selinger HA. Prevalence of polycythemia vera and essential thrombocythemia. Am J Hematol. 2008;83(5): 359–62.

    PubMed  Google Scholar 

  129. Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer. 1990;66(3):549–56. Aug 1.

    PubMed  CAS  Google Scholar 

  130. Nobacht S, Cruysberg JR, Deutman AF. Peripheral retinal nonperfusion associated with essential thrombocytosis. Am J Ophthalmol. 1999;127:101–2.

    PubMed  CAS  Google Scholar 

  131. Liu M, Lee AG, Rice L, Lambert HM. Bilateral retinal vascular occlusive disease in essential thrombocythemia. Retina. 1999;19(6):563–4.

    PubMed  CAS  Google Scholar 

  132. Imasawa M, Iijima H. Multiple retinal vein occlusions in essential thrombocythemia. Am J Ophthalmol. 2002;133:152–5.

    PubMed  Google Scholar 

  133. Ciurea SO, Merchant D, Mahmud N, Ishii T, Zhao Y, Hu W, Bruno E, Barosi G, Xu M, Hoffman R. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood. 2007;110(3):986–93. Aug 1.

    PubMed  CAS  Google Scholar 

  134. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23(33):8520–30. Nov 20.

    PubMed  CAS  Google Scholar 

  135. Baker RI, Manoharan A. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time. Eur J Haematol. 1988;40(3): 267–72.

    PubMed  CAS  Google Scholar 

  136. Levine RL, Belisle C, Wadleigh M, Zahrieh D, Lee S, et al. X-inactivation based clonality analysis and quantitative JAK2V617F assessment reveals a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F negative ET and MMM patients with clonal hematopoiesis. Blood. 2006;107:4139–41.

    PubMed  CAS  Google Scholar 

  137. Camplbell PJ, Griesshammer M, Dohner K, Dohner H, Kusec R, et al. V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis. Blood. 2005;105:2098–100.

    Google Scholar 

  138. Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, et al. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 2006;3(7):e270.

    PubMed  Google Scholar 

  139. McAuliffe PF, Hall MJ, Castro-Malaspina H, Heinemann MH. Use of ganciclovir implant for treating cytomegalovirus retinitis secondary to immunosuppression after bone marrow transplantation. Am J Ophthalmol. 1997;123(5):702–3.

    PubMed  CAS  Google Scholar 

  140. Blood AM, Lowenthal EA, Nowakowski RW. Retinopathy secondary to anemia from myeloid metaplasia in polycythemia vera. J Am Optom Assoc. 1997;68(11):734–8.

    PubMed  CAS  Google Scholar 

  141. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19(4):379–90.

    Google Scholar 

  142. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–51.

    PubMed  CAS  Google Scholar 

  143. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009;2009:523–31.

    Google Scholar 

  144. Han X, Kilfoy B, Zheng T, et al. Lymphoma survival patterns by WHO subtype in the United States, 1973–2003. Cancer Causes Control. 2008;19:841.

    PubMed  Google Scholar 

  145. Soslow RA, Baergen RN, Warnke RA. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer. 1999;85(12):2648–54. Jun 15.

    PubMed  CAS  Google Scholar 

  146. Guyer DR, Schachat AP, Vitale S, et al. Leukemic retinopathy: relationship between fundus lesions and hematologic parameters at diagnosis. Ophthalmology. 1989;96:860–4.

    PubMed  CAS  Google Scholar 

  147. Schachat AP, Markowitz JA, Guyer DR, Burke PJ, Karp JE, Graham ML. Ophthalmic manifestations of leukemia. Arch Ophthalmol. 1989;107(5):697–700.

    PubMed  CAS  Google Scholar 

  148. Allen RA, Straatsma BR. Ocular involvement in leukaemia and allied disorders. Arch Ophthalmol. 1961;66:490–508.

    PubMed  CAS  Google Scholar 

  149. Gordon KB, Rugo HS, Duncan JL, Irvine AR, Howes Jr EL, O’Brien JM, Carter SR. Ocular manifestations of leukemia: leukemic infiltration versus infectious process. Ophthalmology. 2001;108(12): 2293–300.

    PubMed  CAS  Google Scholar 

  150. Coskuncan NM, Jabs DA, Dunn JP, Haller JA, Green WR, Vogelsang GB, Santos GW. The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol. 1994;112(3):372–9.

    PubMed  CAS  Google Scholar 

  151. Duane TD, Osher RH, Green WR. White centered hemorrhages: their significance. Ophthalmology. 1980;87:66–9.

    PubMed  CAS  Google Scholar 

  152. Brown GC, Brown MM, Hiller T, et al. Cotton-wool spots. Retina. 1985;5:206–14.

    PubMed  CAS  Google Scholar 

  153. Wu L, Calderón M, Hernández G, Marbis J, Ramírez V. Bilateral exudative retinal detachment as the first sign of relapsing acute myelogenous leukaemia. Clin Experiment Ophthalmol. 2006;34(6):623–5. Aug.

    PubMed  Google Scholar 

  154. Frank RN, Ryan Jr SJ. Peripheral retinal neovascularization with chronic myelogenous leukaemia. Arch Ophthalmol. 1972;87:585–9.

    PubMed  CAS  Google Scholar 

  155. Jampol LM, Goldberg MF, Busse B. Peripheral retinal microaneurysms in chronic leukemia. Am J Ophthalmol. 1975;80(2):242–8. Aug.

    PubMed  CAS  Google Scholar 

  156. Melberg NS, Grand MG, Rup D. The impact of acute lymphocytic leukemia on diabetic retinopathy. J Pediatr Hematol Oncol. 1995;17(1):81–4. Feb.

    PubMed  CAS  Google Scholar 

  157. López-Jiménez J, Sánchez A, Fernández CS, Gutiérrez C, Herrera P, Odriozola J. Cyclosporine-induced retinal toxic blindness. Bone Marrow Transplant. 1997;20(3):243–5. Aug.

    PubMed  Google Scholar 

  158. Lin FC, Chen JT, Horng CT. Bilateral central retinal artery occlusion associated with leukemic optic neuropathy. Can J Ophthalmol. 2007;42(5):759–60. Oct.

    PubMed  Google Scholar 

  159. Jackson N, Reddy SC, Harun MH, Quah SH, Low HC. Macular haemorrhage in adult acute leukaemia patients at presentation and the risk of subsequent intracranial haemorrhage. Br J Haematol. 1997;98(1):204–9. Jul.

    PubMed  CAS  Google Scholar 

  160. Anderton L, Amoaku WM, Noble BA. Retinal and optic disc neovascularization in leukaemia. Acta Ophthalmol (Copenh). 1994;72(6):752–6. Dec.

    CAS  Google Scholar 

  161. Schworm HD, Nasemann JE, Schriever S. Subretinal hypopyon in prolymphocytic leukaemia. Br J Ophthalmol. 1995;79:863–4.

    PubMed  CAS  Google Scholar 

  162. Fackler TK, Bearelly S, Odom T, Fekrat S, Cooney MJ. Acute lymphoblastic leukemia presenting as bilateral serous macular detachments. Retina. 2006;26(6):710–2. Jul–Aug.

    PubMed  Google Scholar 

  163. Buchan J, McKibbin M, Burton T. The prevalence of ocular disease in chronic lymphocytic leukaemia. Eye (Lond). 2003;17(1):27–30.

    CAS  Google Scholar 

  164. Kalina PH, Campbell RJ. Aspergillus terreus endophthalmitis in a patient with chronic lymphocytic leukemia. Arch Ophthalmol. 1991 ;109(1): 102–3.

    PubMed  CAS  Google Scholar 

  165. Machado Od Ode O, Gonçalves R, Fernandes EM, Campos WR, Oréfice F, Curi AL. Bilateral Aspergillusendophthalmitis in a patient with chronic lymphocytic leukaemia. Br J Ophthalmol. 2003;87(11):1429–30.

    PubMed  Google Scholar 

  166. Phillips WB, Shields CL, Shields JA, Eagle Jr RC, Masciulli L, Yarian DL. Nocardia choroidal abscess. Br J Ophthalmol. 1992;76(11):694–6.

    PubMed  CAS  Google Scholar 

  167. Calfa CJ, Lossos IS, Ruiz P, Davis JL. Ocular involvement as the initial manifestation of T-cell chronic lymphocytic leukemia. Am J Ophthalmol. 2007;144(2):326–9. Aug.

    PubMed  Google Scholar 

  168. Coupland SE, Anastassiou G, Bornfeld N, Hummel M, Stein H. Primary intraocular lymphoma of T-cell type: report of a case and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2005;243(3): 189–97.

    PubMed  Google Scholar 

  169. Bhat PV, Jakobiec FA, Papaliodis G, Sobrin L. Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation. Am J Ophthalmol. 2009;148(3):350–60. Sep.

    PubMed  CAS  Google Scholar 

  170. Brown SM, Jampol LM, Cantrill HL. Intraocular lymphoma presenting as retinal vasculitis. Surv Ophthalmol. 1994;39(2):133–40. Sep–Oct.

    PubMed  CAS  Google Scholar 

  171. Cohen RG, Hedges 3rd TR, Duker JS. Central retinal artery occlusion in a child with T-cell lymphoma. Am J Ophthalmol. 1995;120(1):118–20. Jul.

    PubMed  CAS  Google Scholar 

  172. Di Maria A, Redaelli C, Canevari A, Pagnucco G, Martinetti M, Bianchi PE. Unilateral retinal ­vasculitis associated with hairy cell leukaemia: immunogenetic study. Ophthalmologica. 1998;212(5):355–7.

    PubMed  Google Scholar 

  173. Dadi S, Le Noir S, Asnafi V, Beldjord K, Macintyre EA. Normal and pathological V(D)J recombination: contribution to the understanding of human lymphoid malignancies. Adv Exp Med Biol. 2009;650: 180–94.

    PubMed  CAS  Google Scholar 

  174. Puebla-Osorio N, Zhu C. DNA damage and repair during lymphoid development: antigen receptor diversity, genomic integrity and lymphomagenesis. Immunol Res. 2008;41(2):103–22.

    PubMed  CAS  Google Scholar 

  175. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood. 2006;107(1):265–76. Jan 1.

    PubMed  CAS  Google Scholar 

  176. Croce CM, Erikson J, Ar-Rushdi A, Aden D, Nishikura K. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. Proc Natl Acad Sci USA. 1984;81(10):3170–4. May.

    PubMed  CAS  Google Scholar 

  177. Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Experiment Ophthalmol. 2008;36(6): 564–78. Aug.

    PubMed  Google Scholar 

  178. Singh AD, Damato BE, Pe’er J, Murphree AL, Perry JD. Clinical ophthalmic oncology. 1st ed. China: Saunders; 2007. Print.

    Google Scholar 

  179. Saatci AO, Duzovali O, Ozbek Z, et al. Combined central retinal artery and vein occlusion in a child with systemic non-Hodgkin’s lymphoma. Int Ophthalmol. 1998–1999;22(2):12–7.

    Google Scholar 

  180. Oh KT, Polk TD, Boldt HC, Turner Jr JF. Systemic small noncleaved cell lymphoma presenting as a posterior choroidal mass. Am J Ophthalmol. 1998;125(4):560–2.

    PubMed  CAS  Google Scholar 

  181. Kumar H, Garg SP, Kumar A, Gupta P. Serous macular detachment in lymphoproliferative disorders. Can J Ophthalmol. 1991;26(5):280–2.

    PubMed  CAS  Google Scholar 

  182. Ries LA, Kosary CL, Hankey BF, et al., editors. SEER cancer statistics review: 1973–1994, NIH publ no. 97–2789. Bethesda: National Cancer Institute; 1997.

    Google Scholar 

  183. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49. Jul–Aug.

    PubMed  Google Scholar 

  184. Nieters A, Rohrmann S, Becker N, et al. Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167(9):1081–9. May 1.

    PubMed  Google Scholar 

  185. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425–32. Mar 16.

    PubMed  Google Scholar 

  186. Grufferman S, Cole P, Smith PG, Lukes RJ. Hodgkin’s disease in siblings. N Engl J Med. 1977;296(5):248–50. Feb 3.

    PubMed  CAS  Google Scholar 

  187. Dhaliwal RS, Schachat AP. Leukemias and lymphomas. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson P, editors. The retina. 4th ed. Philadelphia: Mosby; 2005.

    Google Scholar 

  188. Siatkowski RM, Lam BL, Schatz NJ, Glaser JS, Byrne SF, Hughes JR. Optic neuropathy in Hodgkin’s disease. Am J Ophthalmol. 1992;114(5):625–9. Nov 15.

    PubMed  CAS  Google Scholar 

  189. Seelenfreund MH, Freilich DB, Norton L, Chaiken B. Branch retinal artery occlusion in patients with Hodgkin’s disease. Ann Ophthalmol. 1984;16(1): 76–9.

    PubMed  CAS  Google Scholar 

  190. Bishop JE, Salmonsen PC. Presumed intraocular Hodgkin’s disease. Ann Ophthalmol. 1985;17: 589–92.

    PubMed  CAS  Google Scholar 

  191. Toussaint D, Vanderhaeghan JJ. Ocular toxoplasmosis, trigeminal herpes zoster and pulmonary tuberculosis in a patient with Hodgkin’s disease. Ophthalmologica. 1975;171:237–43.

    Google Scholar 

  192. Lissner GS, I’Grady R, Choromokos E. Endogenous intraocular Nocardia asteroidsin Hodgkin’s disease. Am J Ophthalmol. 1978;86:388–94.

    PubMed  CAS  Google Scholar 

  193. Nasir MA, Jaffe GJ. Cytomegalovirus retinitis associated with Hodgkin’s disease. Retina. 1996;16(4):324–7.

    PubMed  CAS  Google Scholar 

  194. Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol. 2007;139(5):730–43. Dec.

    PubMed  CAS  Google Scholar 

  195. Landgren O, Katzmann JA, Hsing AW, Pfeiffer RM, Kyle RA, Yeboah ED, Biritwum RB, Tettey Y, Adjei AA, Larson DR, Dispenzieri A, Melton 3rd LJ, Goldin LR, McMaster ML, Caporaso NE, Rajkumar SV. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc. 2007;82(12):1468–73.

    PubMed  Google Scholar 

  196. The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749–57. Jun.

    Google Scholar 

  197. Brousseau M, Leleu X, Gerard J, Gastinne T, Godon A, Genevieve F, Dib M, Lai JL, Facon T, Zandecki M. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients. Clin Cancer Res. 2007;13(20): 6026–31. Oct 15.

    PubMed  CAS  Google Scholar 

  198. Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002;2(3):175–87.

    PubMed  CAS  Google Scholar 

  199. Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA, Kyle RA, Gertz MA, Greipp PR, Dewald GW. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood. 2002;100(4):1417–24. Aug 15.

    PubMed  CAS  Google Scholar 

  200. Ho AC, Benson WE, Wong J. Unusual immunogammopathy maculopathy. Ophthalmology. 2000;107(6): 1099–103.

    PubMed  CAS  Google Scholar 

  201. Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. Br J Haematol. 2006;134(6):573–89. Sep.

    PubMed  CAS  Google Scholar 

  202. Vanderschueren S, Mylle M, Dierickx D, et al. Monoclonal gammopathy of undetermined significance: significant beyond hematology. Mayo Clin Proc. 2009;84:842.

    PubMed  Google Scholar 

  203. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, et al. Waldenstrom’s macroglobulinemia: clinical features, complications, and management. J Clin Oncol. 2000;18:214.

    PubMed  CAS  Google Scholar 

  204. Groves FD, Travis LB, Devesa SS, et al. Waldenstrom’s macroglobulinemia: incidence patterns in the United States, 1988–1994. Cancer. 1998;82:1078.

    PubMed  CAS  Google Scholar 

  205. Garcia-Sanz R, Montoto S, Torrequebrada A, et al. Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol. 2001;115:575.

    PubMed  CAS  Google Scholar 

  206. Koshiol J, Gridley G, Engels EA, et al. Chronic immune stimulation and subsequent Waldenstrom macroglobulinemia. Arch Intern Med. 2008;168: 1903.

    PubMed  Google Scholar 

  207. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;297:2010.

    PubMed  CAS  Google Scholar 

  208. Kriangkum J, Taylor BJ, Treon SP, et al. Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood. 2004;104:2134.

    PubMed  CAS  Google Scholar 

  209. Stone MJ, Merlini G, Pascual V. Autoantibody activity in Waldenstrom’s macroglobulinemia. Clin Lymphoma. 2005;5:225.

    PubMed  CAS  Google Scholar 

  210. Gertz MA, Kyle RA. Hyperviscosity syndrome. J Intensive Care Med. 1995;10:128.

    PubMed  CAS  Google Scholar 

  211. Merlini G, Baldini L, Broglia C, et al. Prognostic factors in symptomatic Waldenström’s macroglobulinemia. Semin Oncol. 2003;30:211–5.

    PubMed  Google Scholar 

  212. Menke MN, Feke GT, McMeel JW, Branagan A, Hunter Z, Treon SP. Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia. Arch Ophthalmol. 2006;124(11):1601–6.

    PubMed  Google Scholar 

  213. Pilon AF, Rhee PS, Messner LV. Bilateral, persistent serous macular detachments with Waldenström’s macroglobulinemia. Optom Vis Sci. 2005;82(7):573–8.

    PubMed  Google Scholar 

  214. Ogata N, Ida H, Takahashi K, Fukuchi T, Uyama M. Occult retinal pigment epithelial detachment in hyperviscosity syndrome. Ophthalmic Surg Lasers. 2000;31(3):248–52. May–Jun.

    PubMed  CAS  Google Scholar 

  215. Pinna A, Dore S, Dore F, Salis A, Carta F. Bilateral optic disc swelling as the presenting sign of Waldenström’s macroglobulinaemia. Acta Ophthalmol Scand. 2003;81(4):413–5. Aug.

    PubMed  Google Scholar 

  216. Sen HN, Chan CC, Caruso RC, Fariss RN, Nussenblatt RB, Buggage RR. Waldenström’s ­macroglobulinemia-associated retinopathy. Ophthalmology. 2004;111(3):535–9.

    PubMed  Google Scholar 

  217. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33.

    PubMed  Google Scholar 

  218. Phekoo KJ, Schey SA, Richards MA, Bevan DH, Bell S, Gillett D, Moller H. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol. 2004;127(3):299–304. Nov.

    PubMed  CAS  Google Scholar 

  219. Holt JM, Gordon-Smith EC. Retinal abnormalities in diseases of the blood. Br J Ophthalmol. 1969;53(3): 145–60.

    PubMed  CAS  Google Scholar 

  220. Hayasaka S, Ugomori S, Kodama T, Noda S, Setogawa T. Central retinal vein occlusion in two patients with immunoglobulin G multiple myeloma associated with blood hyperviscosity. Ann Ophthalmol. 1993;25(5):191–4.

    PubMed  CAS  Google Scholar 

  221. Brody JM, Butrus SI, Ashraf MF, Rabinowitz AI, Whitmore PV. Multiple myeloma presenting with bilateral exudative macular detachments. Acta Ophthalmol Scand. 1995;73(1):81–2. Feb.

    PubMed  CAS  Google Scholar 

  222. Keung YK, Yung C, Wong JW, Shah F, Cobos E. Association of temporal arteritis, retinal vasculitis, and xanthomatosis with multiple myeloma: case report and literature review. Mayo Clin Proc. 1998;73(7):657–60.

    PubMed  CAS  Google Scholar 

  223. Morgan AE, Shields JA, Shields CL, Piccone MR, Harrison SA. Presumed malignant plasmacytoma of the choroid as the first manifestation of multiple myeloma. Retina. 2003;23(6):867–8. Dec.

    PubMed  Google Scholar 

  224. Grogan TM, Van Camp B, Kyle RA. Plasma cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 142.

    Google Scholar 

  225. Levy-Clarke GA, Greenman D, Sieving PC, Byrnes G, Shen D, Nussenblatt R, Chan CC. Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. Surv Ophthalmol. 2008;53(3):285–95. May–Jun.

    PubMed  Google Scholar 

  226. Picard FJ, Coulthart MB, Oger J, King EE, Kim S, Arp J, Rice GP, Dekaban GA. Human T-lymphotropic virus type 1 in coastal natives of British Columbia: phylogenetic affinities and possible origins. J Virol. 1995;69(11):7248–56.

    PubMed  CAS  Google Scholar 

  227. Taylor G. Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma. J Clin Pathol. 2007;60(12):1392–6.

    PubMed  CAS  Google Scholar 

  228. Merle H, Donnio A, Gonin C, Jean-Charles A, Panelatti G, Plumelle Y. Retinal vasculitis caused by adult T-cell leukemia/lymphoma. Jpn J Ophthalmol. 2005;49(1):41–5. Jan–Feb.

    PubMed  Google Scholar 

  229. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973–2002. Arch Dermatol. 2007;143(7):854–9.

    PubMed  Google Scholar 

  230. Erny BC, Egbert PR, Peat IM, Shorrock K, Rosenthal AR. Intraocular involvement with subretinal pigment ­epithelium infiltrates by mycosis fungoides. Br J Ophthalmol. 1991;75(11):698–701.

    PubMed  CAS  Google Scholar 

  231. Lois N, Hiscott PS, Nash J, Wong D. Immunophenotypic shift in a case of mycosis fungoides with vitreous invasion. Arch Ophthalmol. 2000;118(12):1692–4.

    PubMed  CAS  Google Scholar 

  232. Cimino L, Chan CC, Shen D, Masini L, Ilariucci F, Masetti M, Asioli S, Sartori A, Cappuccini L. Ocular involvement in nasal natural killer T-cell lymphoma. Int Ophthalmol. 2009;29(4):275–9. Aug.

    PubMed  Google Scholar 

  233. Ling R, James B. White-centred retinal haemorrhages (Roth spots). Postgrad Med J. 1998;74(876): 581–2. Oct.

    PubMed  CAS  Google Scholar 

  234. Pomeranz HD. Roth spots. Arch Ophthalmol. 2002;120(11):1596.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Cole Eye Institute, Cleveland Clinic, 9500 Euclid Avenue, i-13, Cleveland, OH, 44195, USA

    Eric S. Ahn M.D.

  2. Cleveland Clinic – Cole Eye Institute, 9500 Euclid Avenue, i-13, Cleveland, OH, 44130, USA

    Ahmad Bakir Tarabishy M.D.

  3. Department of Ophthalmology, Cleveland Clinic – Cole Eye Institute, 9500 Euclid Avenue, i-30, Cleveland, OH, 44195, USA

    Andrew P. Schachat M.D.

Authors
  1. Eric S. Ahn M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmad Bakir Tarabishy M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew P. Schachat M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew P. Schachat M.D. .

Editor information

Editors and Affiliations

  1. Johns Hopkins University, School of Medicine, The Retina Division,Wilmer Eye Institute, Al-Oruba Street, PO Box 7191, Riyadh, 1010, Saudi Arabia

    J. Fernando Arévalo

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ahn, E.S., Tarabishy, A.B., Schachat, A.P. (2013). Posterior Pole Manifestations of Hematologic Diseases. In: Arévalo, J. (eds) Retinal and Choroidal Manifestations of Selected Systemic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3646-1_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3646-1_23

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3645-4

  • Online ISBN: 978-1-4614-3646-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation